Skip to main content
. 2024 Mar 28;16(4):472. doi: 10.3390/pharmaceutics16040472

Table 2.

Results from the second heating cycle of the DSC analysis (means of n = 3, ±SD).

Plasticizer PVA 3-82 PVA 4-88
Tg
[°C]
ΔCp
[K/Jg−1]
Tm
[°C]
ΔH
[Jg−1]
Tg
[°C]
ΔCp
[K/Jg−1]
Tm
[°C]
ΔH
[Jg−1]
none 62.6
(±0.3)
0.659
(±0.099)
170.3
(±23.0)
5.450
(±0.453)
67.3
(±0.4)
0.628
(±0.038)
176.7
(±0.4)
11.620
(±0.511)
GLY 38.2
(±2.6)
0.938
(±0.106)
150.3
(±3.2)
3.550
(±0.427)
44.3
(±1.3)
0.774
(±0.034)
166.2
(±1.1)
10.067
(±0.891)
TRI 56.3
(±1.2)
0.912
(±0.023)
129.4
(±1.6)
3.153
(±0.244)
61.9
(±0.9)
0.791
(±0.015)
148.5
(±2.8)
5.4770
(±0.468)
TEC 61.5
(±0.6)
0.871
(±0.036)
155.1
(±0.5)
2.953
(±0.080)
70.7
(±0.4)
0.762
(±0.012)
133.4
(±0.4)
6.250
(±0.646)
PEG 300 44.0
(±0.5)
0.896
(±0.041)
174.0
(±2.5)
2.917
(±0.759)
48.8
(±1.0)
0.725
(±0.045)
178.6
(±0.4)
9.973
(±0.264)
MAN 52.1
(±0.1)
0.801
(±0.013)
157.1
(±0.3)
5.983
(±0.278)
53.3
(±0.5)
0.695
(±0.019)
168.4
(±0.2)
13.603
(±0.146)
SOR 49.9
(±0.1)
0.895
(±0.024)
153.9
(±0.5)
4.745
(±0.106)
50.3
(±0.5)
0.728
(±0.036)
166.9
(±0.7)
12.730
(±0.495)